Lung Cancer Screening Quality Criteria

A Population Perspective
      The assessment of population screening programs through accepted indicators is essential to continuously improve its quality. To do that, appropriate information about the performance of a certain lung cancer screening policy must be collected. Lung cancer screening has been approved in many countries, but there are no accepted homogeneous criteria to measure the quality of its application, results, acceptance, or coverage. In addition to this, there is not much evidence on the indicators that should be used to ensure the effect of lung cancer screening on a given population. This population comprises those attending screening, but nonparticipants should also be included in this assessment. In this comment, we aim to highlight the importance of using already available screening performance indicators and also the need to develop population-based indicators apart from those exclusively used for assessing the management of screening-detected lung cancer events (ie, false-positive and false-negative rates or interval cancers).

      Key Words

      To read this article in full you will need to make a payment


      Subscribe to CHEST
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Perry N.
        • Broeders M.
        • de Wolf C.
        • Törnberg S.
        • Holland R.
        • von Karsa L.
        European guidelines for quality assurance in breast cancer screening and diagnosis. 4th ed. 2006.
        • Arbyn M.
        • Anttila A.
        • Jordan J.
        • et al.
        European guidelines for quality assurance in cervical cancer screening. 2nd ed. [Internet]. Publications Office of the European Union; 2008 [cited February 20, 2021].
        • von Karsa L.
        • Patnick J.
        • Segnan N.
        European guidelines for quality assurance in colorectal cancer screening and diagnosis. 1st ed. [Internet]. 2011 [cited February 20, 2021].
        • Ruano-Ravina A.
        • Pérez-Ríos M.
        • Casàn-Clará P.
        • Provencio-Pulla M.
        Low-dose CT for lung cancer screening.
        Lancet Oncol. 2018; 19: e131-e132
      1. Mazzone PJ, White CS, Kazerooni EA, Smith RA, Thomson CC. Proposed quality metrics for lung cancer screening programs: a national lung cancer roundtable project. Chest. 2021;160(1):368-378.